KLF4 prevented angiotensin II-induced smooth muscle cell senescence by enhancing autophagic activity

Hongjie Xu1, Manli Yu2, Yongchao Yu1

  • 1Department of Cardiovascular Surgery, Institute of Cardiac Surgery, Changhai Hospital, Naval Medical University, Shanghai, China.

Abstract

Insights

Krüppel-like factor 4 (KLF4) overexpression prevents vascular smooth muscle cell (VSMC) senescence induced by angiotensin II (Ang II). This occurs by promoting telomerase reverse transcriptase (TERT)-mediated autophagy, offering potential therapeutic targets for vascular aging.

Area of Science:

  • Cardiovascular Biology
  • Cellular Senescence
  • Molecular Mechanisms

Background:

  • Vascular aging is a key risk factor for cardiovascular diseases.
  • Krüppel-like factor 4 (KLF4) influences vascular smooth muscle cell (VSMC) phenotype in aortic diseases.
  • The role of KLF4 in angiotensin II (Ang II)-induced VSMC senescence requires elucidation.

Purpose of the Study:

  • To investigate the function and mechanism of KLF4 in Ang II-induced VSMC senescence.
  • To determine if KLF4 can mitigate Ang II-mediated cellular aging in VSMCs.

Main Methods:

  • Established a VSMC senescence mouse model using sustained Ang II release.
  • Induced premature VSMC senescence using Ang II in vitro.
  • Assessed cellular senescence via SA-β-gal activity and p53/p16 expression.
  • Evaluated autophagic activity through autophagic flux and marker expression.

Main Results:

  • KLF4 expression initially increased then decreased in Ang II-stimulated aortas and senescent VSMCs.
  • KLF4 overexpression reduced SA-β-gal activity and p53/p16 levels, indicating reduced senescence.
  • KLF4 directly targets telomerase reverse transcriptase (TERT), preventing its decrease under Ang II.
  • KLF4 overexpression enhanced autophagy and antisenescence capabilities in VSMCs.

Conclusions:

  • Overexpression of KLF4 inhibits Ang II-induced VSMC senescence.
  • KLF4 exerts its protective effect by enhancing TERT-mediated autophagy.
  • These findings highlight KLF4 as a potential therapeutic target for vascular aging.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
533
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
969
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
933
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.0K